# K071993: T-Port HP Infusion Port

- Pathway: 510(k) (Traditional)
- Applicant: Pfm Medical, Inc.
- Decided: Oct 17, 2007 after 89 days
- Product code: LJT (Port & Catheter, Implanted, Subcutaneous, Intravascular)
- Device class: 2
- Regulation: 21 CFR 880.5965
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K001901 (2000). 23 ancestors in all.
5 later devices descend from it; 2 cite it directly.
0 of 29 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K000125: Jet Port Plus Catheter System, Clinical Plastic Products SA (2000) Summary page 1.
- K070003: Power Injectable Implantable Infusion Port with Silicone Lumen (Attachable and Pre-Attached), Medcomp (2007) Summary page 1.

## Most influential descendants
- K073210: Modification to: T-Port HP Infusion Port (2007), 4 descendants of its own
- K122767: Nmi Port (2013), 3 descendants of its own
- K131694: Nmi Port II Catheter (2013), 2 descendants of its own
- K190559: SmartPort+ Implantable Ports, SmartPort Plastic Implantable Ports (2020), 0 descendants of its own
- K153228: NMI Port, NMI Port II (2015), 0 descendants of its own

## Indications for use
The T-Port HP Infusion Port is indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medications, IV fluids, parenteral nutrition solutions, blood products and for the withdrawal of blood samples. When used with a power injectable needle, the T-Port HP Infusion Port is indicated for power injection of contrast media. For power injection of contrast media, the maximum recommended infusion rate is 5 ml/sec with a 19G or 20G non-coring power injectable needle or 2 ml/sec with a 22G non-coring power injectable needle.

Source page: https://510kreport.com/device/K071993
Methodology: https://510kreport.com/methodology